You have 9 free searches left this month | for more free features.

palbociclib

Showing 1 - 25 of 184

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer Trial in Orange City (ARV-471 (PF-07850327), Palbociclib, Letrozole)

Recruiting
  • Breast Cancer
  • ARV-471 (PF-07850327)
  • +2 more
  • Orange City, Florida
    Mid Florida Hematology and Oncology Center
Jun 8, 2023

Metastatic Breast Cancer Trial in Al Madinah (Palbociclib)

Not yet recruiting
  • Metastatic Breast Cancer
  • Palbociclib
  • Al Madīnah, AL, Saudi Arabia
    Asmaa Imam Ahmed
Oct 8, 2023

Palbociclib in Canadian Breast Cancer That Has Spread to Other

Not yet recruiting
  • Breast Cancer
  • Palbociclib
  • (no location specified)
Aug 18, 2023

Undifferentiated Pleomorphic Sarcoma Trial in Iowa City (Palbociclib, Pembrolizumab)

Not yet recruiting
  • Undifferentiated Pleomorphic Sarcoma
  • Iowa City, Iowa
    University of Iowa Hospitals & Clinics
Nov 1, 2023

Compare Overall Survival in Medicare Metastatic Breast Cancer

Active, not recruiting
  • Breast Cancer
  • Palbociclib
  • Aromatase Inhibitor
  • New York, New York
    Pfizer New York
Oct 11, 2023

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

Not yet recruiting
  • ccRCC
  • +20 more
  • (no location specified)
Jul 6, 2023

DCIS Trial in Washington (Palbociclib)

Recruiting
  • DCIS
  • Palbociclib
  • Washington, District of Columbia
  • +1 more
Jan 23, 2023

Breast Cancer Trial in Groningen (Palbociclib, FES PET, Letrozole)

Completed
  • Breast Cancer
  • Palbociclib
  • +2 more
  • Groningen, Netherlands
    University Medical Center Groningen
Oct 11, 2022

Head Neck Cancer, Locally Advanced Trial in Bangkok (Palbociclib, Cetuximab, Intensity Modulated Radiation Therapy)

Active, not recruiting
  • Head and Neck Cancer
  • Locally Advanced
  • Palbociclib
  • +2 more
  • Bangkok, Thailand
    Faculty of Medicine, Ramathibodi Hospital
Sep 19, 2022

Advanced Dedifferentiated Liposarcoma, Locally Advanced Dedifferentiated Liposarcoma, Metastatic Dedifferentiated Liposarcoma

Not yet recruiting
  • Advanced Dedifferentiated Liposarcoma
  • +5 more
  • Palbociclib
  • +5 more
  • (no location specified)
Jan 11, 2023

Esophagus Squamous Cell Carcinoma Trial in Beijing (Palbociclib, Afatinib)

Recruiting
  • Esophagus Squamous Cell Carcinoma
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospital, Chinese Academy of Medic
May 17, 2023

Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Therapy Trial in Taipei City, Taipei (Palbociclib, Ribociclib,

Recruiting
  • Breast Cancer
  • +2 more
  • Palbociclib
  • +3 more
  • Taipei City, Taiwan
  • +1 more
Mar 15, 2023

COVID-19 Trial in Brandenburg an der Havel (Palbociclib)

Withdrawn
  • COVID-19
  • Palbociclib
  • Brandenburg an der Havel, Germany
    Universitätsklinikum Brandenburg an der Havel
Nov 3, 2022

Tumor, Solid, Pancreatic Cancer Trial in Chapel Hill (Ulixertinib, Palbociclib)

Recruiting
  • Tumor, Solid
  • +2 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Nov 30, 2022

Renal Cell Carcinoma, Ovarian Carcinoma, Thyroid Carcinoma Trial in Groningen (Olaparib, Lenvatinib, Sunitinib)

Not yet recruiting
  • Renal Cell Carcinoma
  • +4 more
  • Groningen, Netherlands
    University Medical Center Groningen
Jul 13, 2023

Metastatic Breast Cancer (MBC) Trial in United States (Palbociclib, Bicalutamide)

Active, not recruiting
  • Metastatic Breast Cancer (MBC)
  • Basking Ridge, New Jersey
  • +4 more
Oct 31, 2022

Real-World Evidence In Patients Treated With Palbociclib

Recruiting
  • Metastatic Breast Cancer
  • Palbociclib
  • Timisoara, Timiș, Romania
  • +5 more
Dec 7, 2022

Breast Cancer, Head Neck Cancer Trial in Seoul (Palbociclib, Cetuximab, Fulvestrant)

Recruiting
  • Breast Cancer
  • Head and Neck Cancer
  • Palbociclib
  • +3 more
  • Seoul, Seoul-teukbyeolsi [seoul], Korea, Republic of
  • +3 more
Dec 14, 2022

Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Los Angeles (procedure, drug, other)

Terminated
  • Estrogen Receptor Positive
  • +16 more
  • Biopsy of Breast
  • +5 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Sep 22, 2022

Renal Cell Carcinoma Trial in Macquarie University, Haifa (Belzutifan, Palbociclib)

Recruiting
  • Renal Cell Carcinoma
  • Macquarie University, New South Wales, Australia
  • +1 more
Aug 15, 2022

Advanced Clear Cell Renal Cell Carcinoma Trial in Boston (Axitinib, Palbociclib, Avelumab)

Not yet recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • Boston, Massachusetts
  • +2 more
Jun 27, 2022

Breast Cancer Trial (Gedatolisib, Palbociclib, Fulvestrant)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Aug 12, 2022

Breast Cancer Female Trial in Belgium (Palbociclib)

Completed
  • Breast Cancer Female
  • Palbociclib
  • Anderlecht, Belgium
  • +4 more
Jun 23, 2022

Breast Cancer Trial in Worldwide (Ipatasertib, Placebo, Palbociclib)

Active, not recruiting
  • Breast Cancer
  • Atlanta, Georgia
  • +19 more
Dec 5, 2022